NeoGenomics (NASDAQ: NEO) reported Q1 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $23 million versus the consensus estimate of $23.36 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.